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Abstract: Diffuse optical imaging (DOI) is a non invasive technique
allowing the recovery of hemodynamic changes in the brain. Due to the
diffusive nature of photon propagation in turbid media and the fact that
cerebral tissues are located around 1.5 cm under the adult human scalp, DOI
measurements are subject to partial volume errors. DOI measurements are
also sensitive to large pial vessels because oxygenated and deoxygenated
hemoglobin are the dominant chromophores in the near infrared window.
In this study, the effect of the extra-cerebral vasculature in proximity of
the sagittal sinus was investigated for its impact on DOI measurements
simulated over the human adult visual cortex. Numerical Monte Carlo
simulations were performed on two speciﬁc models of the human head
derived from magnetic resonance imaging (MRI) scans. The ﬁrst model
included the extra-cerebral vasculature in which constant hemoglobin con-
centrations were assumed while the second did not. The screening effect of
the vasculature was quantiﬁed by comparing recovered hemoglobin changes
from each model for different optical arrays and regions of activation. A
correction factor accounting for the difference between the recovered and
the simulated hemoglobin changes was computed in each case. The results
show that changes in hemoglobin concentration are better estimated when
the extra-cerebral vasculature is modeled and the correction factors obtained
in this case were at least 1.4-fold lower. The effect of the vasculature was
also examined in a high-density diffuse optical tomography conﬁguration.
In this case, the difference between changes in hemoglobin concentration
recovered with each model was reduced down to 10%.
© 2011 Optical Society of America
OCIS codes: (170.3660)Light propagation in tissues; (110.3080)Infrared imaging; (170.5280)
Photon migration.
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Optical imaging has seen signiﬁcant developments in the last two decades mainly due to its
clinical potential. Optical neuroimaging includes a variety of methods enabling its use across
species including human from premature newborn [1] to elderly [2], nonhuman primate [3],
cat [4,5] and rodent [6]. Diffuse optical imaging studies in human are non-invasive and can be
monitored continuously at bedside, in intensive care units for newborn, children and elderly,
avoiding moving critically ill patients.
Diffuse optical imaging employing near infrared spectroscopy (NIRS) in human has been
utilized in the past during visual stimulation to monitor visual cortical function [7] and estimate
evoked brain activity and tissue oxygenation [8–10]. For example, in [9,11], the authors meas-
ured regional changes in hemoglobin concentrations using an optode array placed 10 mm to the
right of the midline to minimize the sagittal sinus effect. Changes in hemoglobin concentrations
were also assessed when they were induced by a decrease in neuronal activity [12]. While al-
most all functional retinototopic mappings of the visual cortex were investigated using intrinsic
optical imaging in monkey [3], cat [5] and rat [6] visual cortex, recent work proposed to use
high-density diffuse optical tomography (DOT) approaches to reveal phase-encoded mapping
of the human visual cortex’s retinotopic organization [13]. In particular, the authors employed a
multi-distance high-density optical grid to show that diffuse optical tomography is able to mea-
sure complex organized structures in the visual cortex. In [14], the authors demonstrated, using
the same methodology, resting-state functional connectivity in the human brain. This approach
enabled the recovery of two-dimensional maps of changes in oxygenated [HbO] and deoxy-
genated [HbR] hemoglobin concentrations with a 1 cm lateral and cortical depth resolutions. In
all cases, the optical array conﬁguration was horizontally centered near the inion.
The localization of focal hemodynamic activation in the brain is non accurate and recovered
hemoglobin concentrations suffer from signiﬁcant partial volume errors due to the diffusive
nature of the propagation of light in biological tissues [15]. These errors originate from the
limited depth sensitivity of DOI, leading to an underestimation of changes in hemoglobin con-
centration. The partial volume error depends on the position and the magnitude of the activation
(in terms of absorption change) and is sensitive to the optical properties of tissues [16]. Photon
propagation theory demonstrates that the trajectory of light in tissue is longer than the source-
detector distance and that a multiplicative factor can account for this difference. This factor
is known as the differential pathlength factor [17,18] and varies with the wavelength of light.
However, in functional study, only a fraction of the light travels in the activated regions of the
brain and this phenomenon is known to create partial volume error.
In order to use NIRS data in vascular modeling [19] to compute metabolic parameters, NIRS
measurements must ﬁrst be corrected for partial volume errors. This correction is needed as the
absolute changes occurring in the cortex during cerebral activity are required in the modeling
process [20] and can be achieved using numerical simulations [21]. When NIRS measurements
are performed over a region where the contribution of extra-cerebral vasculature is negligible,
the numerical simulation can use a segmented head model containing the following tissue types
of the human head: scalp, skull, cerebrospinal ﬂuid (CSF) and brain tissue (including the white
and the gray matters). However, when measurements are performed over an area in the vicinity
of large pial vessels such as the sagittal sinus, additional partial volume errors might arise due
to the high sensitivity of DOI to blood. These structures contain whole blood, both oxy- and
deoxyhemoglobin, which strongly absorb light in the near-infrared (NIR) spectrum. The goal
of this study is to quantify the inﬂuence of the extra-cerebral vasculature on DOI measure-
ments. A similar effect was previously explored on blood ﬂow measurements [22,23] and on
hemoglobin oxygenation measurements with time-resolved reﬂectance spectroscopy [24]. As
far as we know, this is the ﬁrst study in which the effect of the extra-cerebral vasculature on
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In this study, the inﬂuence of the extra-cerebral vasculature on DOI measurements was inves-
tigated by including this vasculature in the 3D anatomical head model. The geometrical struc-
ture of these vessels was obtained from a 3D phase contrast angiography MRI sequence. Light
propagation was modeled using a numerical Monte Carlo (MC) approach and simulations were
carried out in two speciﬁc anatomical models. The ﬁrst model included the extra-cerebral vas-
culature while the second was build with only the typical tissues: scalp, skull, CSF and brain.
Optical properties of the extra-cerebral vasculature were assigned to those of whole blood.
Brain activation was simulated by applying a change in the absorption coefﬁcient in a speciﬁc
and limited region of the brain tissue. The changes in hemoglobin concentration recovered with
each model were compared and correction factors accounting for the difference between the
recovered and the simulated changes were computed. This procedure was repeated for differ-
ent optical arrays and regions of activation located in the proximity of the sagittal sinus. This
technique was ﬁnally applied in the context of a high-density diffuse optical tomography.
2. Methods
2.1. MR imaging technique
The images were acquired on a 3T Trio TIM MR device (Siemens Healthcare, Erlangen, Ger-
many). One volunteer was scanned using a 12-channel matrix head coil. Written consent was
obtained from the subject prior to the study and the subject received ﬁnancial compensation.
The structural image was acquired with a 3D MPRAGE. Imaging times were TE/TR/TI =
4.18/2300/900 ms and the ﬁeld of view (FOV) was 256×224mm2 with partial Fourier 6/8
and an acceleration factor of 2 with GRAPPA (Generalized Autocalibrating Partially Parallel
Acquisition) reconstruction. 176 slices were acquired with a thickness of 1 mm for isotropic
voxel volume (1 mm3) and a bandwidth of 150 Hz/px.
A phase contrast (PC) technique was selected because we required a high spatial resolution
brain peripheral veins angiography without contrast agent injection [25]. This sequence allowed
good stationary tissue suppression and easy venous blood signal selection using a velocity en-
coding (VENC) approach. Improved sensitivity was obtained by making the sequence sensitive
to venous blood in three perpendicular spatial directions [26] leading to a clear identiﬁcation of
the venous path in 3D. A saturation band was also applied below the volume of interest in the
superior-inferior direction to suppress arterial blood signal. The saturation band was 110 mm
thick below the volume of interest and perpendicular to the carotid arteries. The PC sequence
was based on a high resolution 3D gradient recalled echo scheme. The sequence parameters
were: FOV = 200.0×168.8×129.6mm3, matrix = 256×216×144 to obtain a nearly isotropic
voxel volume (Vvoxel =0.78×0.78×0.90mm3).The selected VENC was 5mm/sforthe plane
described by the right-left and anterior-posterior encoding. The total sequence duration was 11
min and 40 sec. The bandwidth was 300 Hz/px and imaging times were TR/TE = 80.9/10.3
ms. The ﬂip angle was set to 15◦ and an image GRAPPA with acceleration factor of 2 with 24
integrated reference scans over one average were used for reconstruction.
2.2. Anatomical head models
Two speciﬁc anatomical head models were created from MRI data segmented with SPM5
(Wellcome Trust Centre for Neuroimaging, UCL, London, UK) and FSL (Analysis Group, FM-
RIB, Oxford, UK) softwares. Both models were segmented in the following tissue types: scalp,
skull, CSF, gray (GM) and white (WM) matters. The ﬁrst model included the extra-cerebral
vasculature and was derived by the co-registration of the 3D PC angiography in the structural
T1-weighted image space, while the second did not incorporate the vasculature. Dimensions
for both models were 155×214×130 mm3 of isotropic voxels of 1 mm3.
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line absorptioncoefﬁcients μa0 [mm−1],scattering coefﬁcients μs [mm−1],anisotropicfac-
tors g and refractive indexes n; Note that brain tissue included gray and white matters [21]
Tissue λ = 690 nm λ = 830 nm
μa0 μs gnμa0 μs gn
Scalp 0.0159 8.00 .9 1.4 0.0191 6.60 .9 1.4
Skull 0.0101 10.0 0.9 1.4 0.0136 8.6 0.9 1.4
CSF 0.0004 0.10 .9 1.4 0.0026 0.10 .9 1.4
Brain 0.0178 12.5 0.9 1.4 0.0186 11.1 0.9 1.4
Vasculature 0.5745 74.50 .985 1.4 0.4758 67.50 .992 1.4
2.3. Optical properties
The baseline optical properties used in the MC simulations for scalp, skull, CSF, gray and white
matters were taken from [21] at two speciﬁc wavelengths (λ) of 690 and 830 nm in the NIR
spectrum (see Table 1). To compute the absorption coefﬁcient in the extra-cerebral vasculature,
we assumed that oxy- and deoxyhemoglobin were the only chromophores with concentrations
CHbO and CHbR, respectively. Baseline absorption coefﬁcients μλ
a0 were computed from
μλ
a0 = 2.303

ξλ
HbOCHbO+ξλ
HbRCHbR

(1)
where ξλ
HbO and ξλ
HbR are the extinction coefﬁcients for HbO and HbR, respectively.
The NIR absorption is higher in the vasculature than in other tissues because the content
is mainly whole blood. In the following, it is assumed that oxygenated blood is composed of
150 grams (g) of hemoglobin per liter ( ) of blood with a hemoglobin molar mass of 66500
g/Mol [27]. Sinuses are large veins having a baseline oxygen saturation of approximately
60% [28] and their baseline optical absorption coefﬁcients were computed with Eq. (1) lead-
ing to μ690
a0 = 0.5745 and μ830
a0 = 0.4758 mm−1. Scattering coefﬁcients, anisotropy factors and
refractive indexes were taken from literature [29] and are provided in Table 1.
2.4. Optical array conﬁguration
A set of one optical source and two optical detectors were placed in a horizontal conﬁguration
forming a simple optical array. The distances between the source and the two detectors were set
to 30 and 45 mm, respectively. The optical array was positioned at three locations with respect
to the sagittal sinus (Fig. 1). From conﬁguration 1 to 3, the optical array was translated by 10
mm. The same optical array was also positioned in a vertical conﬁguration at 20 mm to the
right of the midline [10]. Finally, a high-density grid was built and horizontally centered near
the inion to cover the occipital cortex and was composed of 24 sources and 28 detectors [30].
2.5. Region of activation
Three different positions of the activation region were simulated (Fig. 2). Regions of activation
had a diameter between 25 and 30 mm and were located in the right hemisphere. For the high-
density DOT study, regions of activation were ﬂipped to the left hemisphere and vertically
centered with respect to the HD grid (see Fig. 5(a)–5(c)). The distances between the sagittal
sinus and the center of regions A, B and C were 10, 20 and 30 mm, respectively. All activations
were located at a depth between 15 and 17 mm from the skin.
Regions of activation were set in both gray and white matters voxels [21]. Assuming that
[HbO] increases by 9 μMol/  and [HbR] decreases by 3 μMol/  during cerebral activity [31],
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Vasculature
Gray Matter
Source
Detector
3 2
VH D
Fig. 1. Horizontal optical arrays 1–3, vertical array (V) and high density (HD) grid super-
imposed on a 3D coronal view of the anatomical head model including the extra-cerebral
vasculature (black) and the gray matter (GM). Sources and detectors are represented by red
and blue dots, respectively.
changes in the absorption coefﬁcient Δμλ
a were computed using Eq. (1) leading to Δμ690
a =
−0.00062 and Δμ830
a = 0.00155 mm−1 for 690 and 830 nm, respectively. The hemoglobin
content in the vasculature was assumed to remain constant during cerebral activity.
AC B
Fig. 2. 3D coronal view of the anatomical head model including the extra-cerebral vascu-
lature (black), gray matter (GM) and the region of activation (gold). The distance between
the midline and the center of regions A, B and C were 10, 20 and 30 mm, respectively.
2.6. Monte Carlo simulations
Light propagation modeling can be accurately achieved by the use of the radiative transport
equation (RTE) and numerically implemented via probabilistic MC methods [32]. Photon prop-
agation can also be modeled by the so-called diffusion equation being the ﬁrst approximation
(DA) of the RTE [33], which is inaccurate in non- or low-scattering regions as the cerebrospinal
ﬂuid and in the vicinity of the light source. Because of these limitations, several approaches
were developed, including the hybrid radiosity diffusion ﬁnite element model [34] and a cou-
pled RTE-DA approximation model [35]. In this study, the Monte Carlo framework was se-
lectedtoprovide quantitative syntheticmeasurements.Propagation rulesandcode wereadapted
from [32]. All simulations were performed at a zero modulation frequency for both 690 and 830
nm. Photon ﬂuences were computed for two speciﬁc states: activation and baseline. Fluence
during activation state was evaluated with respect to an absorption perturbation Δμλ
a deﬁned
in the region of activation while baseline ﬂuence was computed using homogeneous optical
absorption coefﬁcients described in Table 1. Photon propagations were all simulated with 100
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2.7. Synthetic measurements and recovery of changes in hemoglobin concentration
The Beer-Lambert law [18,36] is used to describe the exponential attenuation of light in tissue
for a speciﬁc wavelength λ. It is expressed as
Φ
Φ0
= exp

−μλ
a DPLλ

(2)
where Φ and Φ0 are the detected and initial light intensities, respectively, and DPL is the
differential pathlength [17,18]. The MC method allowed tracking each photon in each tissue
type providing quantitative and accurate DPL computations. Using the modiﬁed Beer-Lambert
law [37], the change in optical density ΔOD between the baseline (B) and the activated (A)
state at a speciﬁc wavelength λ is related to the change in absorption Δμλ
a through the equation
ΔODλ = −ln

[Φ/Φ0]A
[Φ/Φ0]B

= Δμλ
a DPLλ
B. (3)
In the following, the subscript “Sinus” will refer to a quantity obtained from the model contain-
ingtheextra-cerebral vasculature while“NoSinus” willdesignaquantityobtained fromthesec-
ond model in which the vasculature is not described. For each wavelength, a synthetic measure-
ment ΔODλ
Sinus (Eq. (3)) was ﬁrst generated from the quantities [Φ/Φ0]A,Sinus and [Φ/Φ0]B,Sinus
simulated with the model including the extra-cerebral vasculature (both from Eq. (2)). (Note:
here, the subscript “Sinus” simply emphasizes the fact that the synthetic measurement is gener-
ated from the model including the extra-cerebral vasculature. There is no ΔODλ
NoSinus quantity.)
For each wavelength, change in absorption coefﬁcient Δμλ
a was then recovered using three
different baseline optical pathlengths: (1) the partial pathlength (PPL) of detected light only
within the brain (gray and white matters) [21] with the model including the vasculature (Sinus-
PPL), (2) the partial pathlength (PPL) of detected light only within the brain with the model in
whichthevasculaturewasnotdescribed(NoSinus-PPL),and(3)thetotaldifferentialpathlength
(DPL) of detected light within all the tissues with the model with no vasculature (NoSinus-
DPL). These three quantities were then used to recover changes in absorption such that
Δμλ
a,Sinus-PPL =
ΔODλ
Sinus
PPLλ
B,Sinus
, (4)
and
Δμλ
a,NoSinus-PPL =
ΔODλ
Sinus
PPLλ
B,NoSinus
, and Δμλ
a,NoSinus-DPL =
ΔODλ
Sinus
DPLλ
B,NoSinus
. (5)
The optical pathlengths were computed as weighted averages with all detected photons. The
weights were computed by summing the intensity of each individual photon at the detector and
took into account the absorption coefﬁcient in each tissue. Changes in absorption from Eq. (4)
and Eq. (5) were then converted in changes in hemoglobin concentration ΔCHbO and ΔCHbR
using Eq. (1) for λ =[ 690,830].
Here, the PPL was computed only within the brain as opposed to the traditional deﬁnition in
which the pathlength is evaluated only within a given region of activation [38]. The rationale
for this consideration is justiﬁed by the fact that in functional NIRS study, the spatial location
of this focal “region of activation” is generally unknown. Thus, the PPL computed only within
the brain is reﬂecting a more realistic approximation when no a priori information such as
simultaneous fMRI activation map is available to provide localization of the activated area.
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High-density diffuse optical tomography combines multiple measurements collected at multi-
ple source-detector separations in order to improve the localization and the quantiﬁcation of
cerebral activity. A high-density grid similar to that of [30] was simulated to investigate the
effect of the extra-cerebral vasculature in a diffuse optical tomography application. The HD
grid yielded a total of 212 ﬁrst- and second-nearest neighbor measurements (Fig. 1). The cor-
responding source-detector distances were 13 and 30 mm [13,30].
Light propagation was modeled for the two anatomical head models using the same Monte
Carlo approach described in section 2.6. Sensitivity matrices of each measurement was trun-
cated at 60 dB of magnitude signal loss [13,32]. A randomly distributed Gaussian noise was
added to the generated measurements. The variance was selected from an in vivo experiment
involvingtheoccipitallobe[39]andthenoisetosignalratiowassetto0.15%[40].Allmeasure-
ments were linearly regressed by removing a global signal contribution due to the ﬁrst-nearest
neighbor measurements [30]. Resulting measurements were then used for reconstruction.
Spatial reconstruction of change in absorption coefﬁcient was carried out using a Moore-
Penrose regularization approach [41]. The inverse problem consisted of estimating the vector
of change in absorption Δμa =[ Δμ690
a ,Δμ830
a ]T assuming the knowledge of the light sensitivity
matrix M and the vector of measurements y =[ y690,y830]T for wavelength λ =[ 690,830], such
that
MΔμa = y with M =[ M690,M830] and Mλ =
Nmea
∑
i=1
Nvox
∑
j=1
Φ0(rs,i,rj,λ)Φ0(rj,rd,i,λ) (6)
where rs,i and rd,i are the source and detector positions, respectively. This formulation was
possible by the use of the Rytov approximation [33]. The problem is typically ill-posed because
the number of measurements Nmea is much less than the number of estimates (number of voxels
Nvox). The Moore-Penrose approach helps inverting M from Eq. (6) by writing the solution
such that
Δμa = MT 
MMT +γI
−1
 	
 
P
Δy with I =
1

diag(MMT)+β
(7)
where Δy was the difference between activated and baseline measurements, and γ = 10−5 and
β = 10−2 were regularization parameters [40]. The Moore-Penrose inverse matrix was deﬁned
by the variable P from Eq. (7).
A realistic measurement ΔySinus was simulated with the model including the vasculature
(Sinus) and the vector Δμa from Eq. (7) was then recovered using the two head model inverse
matrices (Sinus and NoSinus), i.e.
Δμa,Sinus = PSinusΔySinus and Δμa,NoSinus = PNoSinusΔySinus. (8)
Changes in absorption from Eq. (8) were then converted in changes in hemoglobin concentra-
tion ΔCHbO and ΔCHbR using Eq. (1) for λ =[690,830]. All reconstruction images were created
in a 2mm3 resolution [13] and re-interpolated in the original volume (1mm3). Images con-
sisted of posterior coronal projections of a particular cortical shell of 1 cm of thickness, where
the scalp and the skull have been removed [13]. The ﬁnal images were restricted in the sagittal
and axial planes to correspond with the ﬁeld of view of the HD grid.
The reconstruction images recovered with and without extra-cerebral vasculature were com-
pared and the absolute difference between the two images was also computed. An image rep-
resenting this difference in percentage was generated by normalizing the initial absolute differ-
ence image by a constant. This constant was given by the difference between averaged values
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the image reconstructed from the model including the extra-cerebral vasculature.
 
 
Δ
C
H
b
O
 
[
μ
M
o
l
/
l
i
t
e
r
]
Δ
C
H
b
O
 
[
μ
M
o
l
/
l
i
t
e
r
]
(a) A-1 (b) A-2
(c) A-3 (d) A-V (vertical)
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Fig. 3. (a)–(d) 3D coronal views of the anatomical head model including the extra-cerebral
vasculature (in black) and the region of activation A (in gold) superimposed with optical
arrays 1, 2, 3 and V, respectively. Sources and detectors are represented by red and blue
dots, respectively. (e)–(f) Corresponding recovered changes in oxyhemoglobin concentra-
tion ΔCHbO for source-detector distances of 30 and 45 mm, respectively. Four values are
represented and correspond to: (blue) true change (9μMol/ ) simulated in the region of
activation, (cyan: Sinus-PPL) change recovered using the anatomical model including the
extra-cerebral vasculature and the partial pathlength, (yellow and dark red) changes recov-
ered using the head model with no vasculature and the partial pathlength (NoSinus-PPL),
and the total differential pathlength (NoSinus-DPL).
3. Results
Recovered values for ΔCHbO are illustrated in Fig. 3 for different positions of the optical array
and in Fig. 4 for different positions of the region of activation. In both ﬁgures, panel (a)–(d)
shows 3D coronal views of the anatomical head model including the extra-cerebral vasculature
(in black) and the region of activation (in gold) superimposed with the optical arrays. Sources
and detectors are represented by red and blue dots, respectively. The corresponding recovered
changes in oxyhemoglobin concentration ΔCHbO are illustrated in bar graphs in histograms (e)
and (f) for source-detector distances of 30 and 45 mm, respectively. The results are shown
for the three recovery procedures: (1) using the anatomical model including the extra-cerebral
vasculature (cyan: Sinus-PPL), (2) using the anatomical model where the extra-cerebral vas-
culature was not modeled and based on brain partial pathlengths (yellow: NoSinus-PPL), and
(3) with total differential pathlength (dark red: NoSinus-DPL). The corresponding correction
factors computed as the ratio between the true and recovered hemoglobin changes are listed in
Table 2. Recovered values for ΔCHbR were similar and are not shown.
Hemoglobin concentration changes recovered with the model including the extra-cerebral
vasculature (Sinus-PPL) at 30 mm varied between 21 and 81% of the true value (9μMol/ ),
which corresponded to correction factors starting at 4.7 and decreasing to 1.3, respectively. In
simulation A-3 (Fig. 3(c)), where the optical array entirely overlapped the sagittal sinus, and
C-2 (Fig. 4(d)), where the region of activation was located at 30 mm from the midline, the
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ered with the model including the vasculature (Sinus-PPL) at 45 mm were all between 23 and
64% of the simulated change, which corresponded to correction factors ranging from 4.4 and
decreasing to 1.6, respectively.
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Fig. 4. (a)–(d) 3D coronal views of the anatomical head model including the extra-cerebral
vasculature (in black) and the regions of activation B and C (in gold) superimposed with
optical arrays 1 and 2, respectively. Sources and detectors are represented by red and blue
dots, respectively. (e)–(f) Corresponding recovered changes in oxyhemoglobin concentra-
tion ΔCHbO for source-detector distances of 30 and 45 mm, respectively. Four values are
illustrated and correspond to: (blue) true change (9μMol/ ) simulated in the region of
activation, (cyan: Sinus-PPL) change recovered using the head model containing the extra-
cerebral vasculature and the partial pathlength, (yellow and dark red) changes recovered
when the vasculature was not taken into account and using the partial pathlength (NoSinus-
PPL), and the total differential pathlength (NoSinus-DPL).
Table 2. Correction factors [no unit] for ΔCHbO computed by the ratio between the true and
the recovered change
Conﬁg.
Sinus-PPL NoSinus-PPL NoSinus-DPL
30 mm 45 mm 30 mm 45 mm 30 mm 45 mm
A-1 1.3 2.1 2.2 2.9 46.9 23.5
A-2 1.5 1.6 6.4 3.2 123.4 26.5
A-3 6.2 2.2 29.5 4.5 576.2 38.5
A-V 3.7 2.5 3.9 3.0 49.7 21.4
B-1 1.4 1.6 2.4 2.2 51.5 18.1
B-2 2.3 1.7 9.7 3.5 186.1 29.0
C-1 4.7 2.3 8.1 3.2 173.5 26.7
C-2 19.1 4.4 81.8 9.3 1567.4 75.6
The concentration changes recovered with no vasculature and using partial pathlength
(NoSinus-PPL) were lower and reached not more than between 1 and 45% of the true change
for 30 and 45 mm, respectively. The correction factors for source-detector distance of 30 mm
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tors obtained with no vasculature and using total differential pathlength (NoSinus-DPL) were
markedly higher and are listed in Table 2. When considering the extra-cerebral vasculature in
the head model, the correction factors were at least 1.4-fold lower than the values computed
with no vasculature (except for A-V: at least 1.1-fold). In the absence of the extra-cerebral vas-
culature, the correction factors computed using partial pathlength (NoSinus-PPL) were at least
7-fold lower than the values computed with total differential pathlength (NoSinus-DPL).
Table 3. Baseline Brain partial (PPL) and total differential (DPL) pathlengths [mm]
Sinus NoSinus
690 nm 830 nm 690 nm 830 nm
30 mm 45 mm 30 mm 45 mm 30 mm 45 mm 30 mm 45 mm
A-1
PPL 4.72 2 .23 .92 2 .08 .73 5 .26 .82 9 .7
DPL – – – – 176.9 282.5 146.3 245.2
PPL 2.3 17.6 1.9 13.7 10.9 33.2 7.9 29.1 A-2
DPL – – – – 187.8 278.5 153.6 236.9
A-3
PPL 1.81 5 .01 .61 2 .61 0 .12 9 .37 .62 6 .0
DPL – – – – 181.8 262.8 149.0 221.5
PPL 13.4 30.5 10.9 27.2 14.2 35.8 11.3 32.9 A-V DPL – – – – 176.2 264.5 146.2 231.1
Baseline brain partial (PPL) and total differential (DPL) pathlengths [mm] of all cases pre-
sented in Fig. 3 and Fig. 4 are compiled in Table 3 for both wavelengths of 690 and 830 nm
as well as for both head models (Sinus and NoSinus). For the head model including the vas-
culature (Sinus), PPL vary from 1.6 to 30.5 mm. Case A-V presents higher pathlength values
since the optical arrays is positioned parallel to the sagittal sinus (vertical position). When the
extra-cerebral vasculature is not described, PPL vary from 6.8 to 35.8 mm while total DPL from
146.2 to 282.5 mm. Pathlengths have higher values in this conﬁguration (NoSinus) because of
the absence of the vasculature. Baseline pathlengths from cases B-1 and C-1 are identical to
that of case A-1 while cases B-2 and C-2 to case A-2 because of the identical optical arrays
used to propagate light at 690 and 830 nm.
Table 4. Correction factors [no unit] when recovering ΔCHbO with traditional partial path-
length (tPPL) of detected photons within only the given region of activation for cases de-
scribed in Fig. 3; Cases from Fig. 4 yield similar results
Conﬁg.
A-1 A-2 A-3 A-V
30 mm 45 mm 30 mm 45 mm 30 mm 45 mm 30 mm 45 mm
Sinus 1.02 1.02 1.02 1.02 1.02 1.03 1.02 1.02
NoSinus 1.64 1.48 3.92 1.92 9.55 2.12 1.11 1.34
Table 4 shows correction factors computed when considering the partial pathlength with de-
tected photons having traveled only in the given region of activation (Fig. 2), i.e. where the
change in absorption was introduced [21,38], as opposed to brain PPL used to calculate cor-
rection factors from Table 2. Correction factors are presented for the four cases of Fig. 3 in
which the traditional partial pathlength, noted “tPPL” for the purpose of this study, was consid-
ered. As expected, the recovery is much more accurate for the two head models, especially for
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model without vasculature. Case A-V shows the lower values (1.11 and 1.34 for 30 and 45 mm,
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Fig. 5. (a)–(c) 3D coronal views of the anatomical head model including the extra-cerebral
vasculature (in black) and the regions of activation A, B and C (in gold) superimposed
with the HD grid. Sources and detectors are represented by red and blue dots, respec-
tively. A true change ΔCHbO = 9μMol/  was simulated in the region of activation. (d)–(f)
Corresponding recovered changes in oxyhemoglobin concentration ΔCSinus
HbO estimated with
the model including the extra-cerebral vasculature (Sinus). (g)–(i) Corresponding recov-
ered ΔCNoSinus
HbO estimated when the vasculature was not modeled (No Sinus). (j)–(l) Corre-
sponding normalized differences in percentage between ΔCHbO reconstructed from the two
anatomical models. All images were posterior coronal projections of a cortical shell of 1
cm of thickness and represent the ﬁeld of view of the HD grid when removing the scalp
and the skull [13]. The white dashed circle superimposed on each 9 reconstruction maps
indicated the diameter of the region of activation.
Results of the simulations with the HD grid are illustrated in Fig. 5. Panel (a)–(c) depicts
3D coronal views of the anatomical head model including the extra-cerebral vasculature (in
black) and the regions of activation (in gold) superimposed with the HD grid. The sources
and the detectors are represented by red and blue dots, respectively. The recovered changes in
hemoglobin ΔCSinus
HbO estimated with the model including the extra-cerebral vasculature (Sinus)
are illustrated in panel (d)–(f) for different activation regions. Panel (g)–(i) shows correspond-
ing recovered ΔCNoSinus
HbO estimated when the vasculature was not taken into account (No Sinus).
Finally, panel (j)–(l) shows corresponding normalized differences (in percentage) between re-
constructed ΔCHbO from the two anatomical models. The white dashed circle superimposed on
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ical head models shown similar reconstruction maps of ΔCHbO varying from 0 to 6μMol/ 
while a change of 9μMol/  was simulated. Both methods were able to reconstruct the change
in hemoglobin concentration with a good spatial accuracy. The difference between the two re-
constructions was less than 10% and decreased as the distance between the simulated activation
and the midline increased (panel (j)–(l)).
4. Discussion
4.1. Vasculature model improves the recovery
Figure 3 and Fig. 4 together with Table 2 and Table 4 illustrate the beneﬁt of recovering changes
in hemoglobin concentration with the model including the extra-cerebral vasculature (Sinus-
PPL). The values recovered with this model were closer to the true value of 9μMol/  than
with the model in which the extra-cerebral vasculature was not described (NoSinus-PPL). The
correction factors that quantify the accuracy of the recovery were at least 1.4 times lower when
using the model describing the vasculature (except for A-V: at least 1.1-fold). This result indi-
cates the necessity of taking into account the extra-cerebral vasculature to compute the partial
pathlength of the photons in brain tissues. The blood contained in the vasculature absorbs an
important quantity of the light emitted by the laser source. Modeling the vasculature helps to
prevent considerable biases in the partial pathlength calculation.
When using the model with no vasculature, the hemoglobin concentration changes recov-
ered using partial pathlength (NoSinus-PPL) were closer to the true value than using the total
differential pathlength (NoSinus-DPL). The correction factors obtained were at least 6 times
lower when using partial pathlength computation. This improvement conﬁrms the use of partial
pathlength to separate the contribution from the superﬁcial tissues [42,43].
4.2. Error reduced using the high-density approach
Increasing the number of sources and detectors leads to an increase in the number of measure-
ments and the possibility to use a multi-distance approach to distinguish superﬁcial and cortex
responses. The high-density tomography approach generally allows for a higher spatial res-
olution and a better quantiﬁcation of change in hemoglobin concentration than the traditional
single source-detector separation method. In this study, the use of a high-density grid to recover
changes in hemoglobin concentration was beneﬁcial for reducing the partial volume error. This
improvement was clearly shown when comparing ΔCHbO estimated with the Beer-Lambert law
from Fig. 3 and Fig. 4, and with the high-density spatial reconstruction shown in Fig. 5(d)–5(i).
Nevertheless, the effect of the extra-cerebral vasculature was still visible but reconstruction
maps computed from the two head models differed by less than 10% (Fig. 5 (j)–(l)). For all
reconstructions, the use of the linear regression from short separations [30] produced similar
beneﬁts of computing partial pathlength [38] in the quantiﬁcation of ΔCHbO from the Beer-
Lambert law. Both methods helped improving the recovery by isolating the signal originated
from the cortex.
4.3. Lateral vs. vertical array conﬁguration
Positioning the optical array parallel to the sagittal sinus at a distance of 2 cm [10] helped to
recover hemoglobin concentrations and appears to be sufﬁcient to avoid the major effect of the
sagittal sinus. In this case, correction factors computed when the vasculature was not taken into
account (NoSinus-PPL) were similar to those computed when considering the extra-cerebral
vasculature in the head model (Sinus-PPL).
#139821 - $15.00 USD Received 16 Dec 2010; revised 10 Feb 2011; accepted 10 Feb 2011; published 23 Feb 2011
(C) 2011 OSA 1 March 2011 / Vol. 2,  No. 3 / BIOMEDICAL OPTICS EXPRESS  6934.4. Brain vs. traditional PPL
In this study, we computed the baseline partial pathlength with detected light within the brain
as opposed to the traditional calculation [21,38] in which only the region of activation is con-
sidered. The motivation behind this approach was justiﬁed by the fact that in the majority of
functional NIRS studies, the spatial description of the region of activation is unknown. Re-
covering hemoglobin concentrations with brain PPL represents a good compromise between
traditional PPL and total DPL computations and offers realistic correction factors. In addition,
total DPL evaluated from the head model in which the vasculature was not described provide
similar values than published work from literature such as [44].
4.5. Effect of the activation region location
The recovered hemoglobin concentration decreased as the distance between the source and the
region of activation increased. This trend was shown in Fig. 4 when comparing cases B–1 and
C–1,andB–2andC–2,respectively.Inbothcomparisons,changesinhemoglobinconcentration
were lower when the region of activation was moved from 20 to 30 mm from the midline. This
decrease was due to a lower sensitivity to the change in the absorption coefﬁcient as the region
of activation was moved away from the source.
4.6. Limitations and future studies
The study was conducted in the occipital lobe because of the size of the sagittal sinus and the
recent use of a high-density diffuse optical tomography approach in the visual cortex [13,14,30,
45,46]. The quantiﬁcation of the effect of the extra-cerebral vasculature would be reproducible
in other cortical areas in which this vasculature is present. However, as the optical probe is
moved toward the forehead, the extent of this effect would probably be lower because the size
of the sagittal sinus decreases as it passes from posterior to anterior regions.
It is also important to precise that the pathlengths and recovered hemoglobin changes pro-
vided by this study are only valid for this particular anatomical structure and for the set of
optical properties given in Table 1, as well as for the optical arrays used to simulate light prop-
agation. Indeed, any changes in these parameters will modify the light distribution and then the
detected optical ﬂuences. However, for the same set of parameters described in this study, we
think that correction factors would be similar from another adult head structure but should not
be used for correcting neonatal or pediatric measurements. The physiology and the composition
of the developing brain as well as the size and shape of the infant’s head will affect considerably
the measurements, e.g. the effect produced by the curvature of the head.
In this study, we assumed that oxygen saturation in the sagittal sinus remained constant
during cerebral activity. The simulations demonstrated the screening effect due to the additional
amount of light blocked by the sagittal sinus during diffuse optical imaging. However, past
works have studied the inﬂuence, mainly from fMRI measurements, of a change in oxygen
saturation in the sinus during cerebral activity. Blood oxygen level dependent (BOLD) signal
used in fMRI to image contrast response to a cognitive task is mainly due to paramagnetic
properties of [HbR]. For this reason, the potential problem of BOLD signal alterations in the
visual cortex produced by the proximity of the sagittal sinus has been investigated [47]. For
instance, Boxerman and colleagues [48] developed a method to quantify BOLD contrast from
extra-vascular contributions using a MC model to improve mapping of neuronal activity. Other
studies have contributed using various fMRI techniques to reduce large vein effects [49,50].
In [51], the authors demonstrated more elevated or shifted [HbR] and [HbO] contrasts in the
vicinity of the sagittal sinus using DOT during electrical stimulations of the rat somatosensory
cortex. In particular, these observations suggested that oxygen saturation changes occur in the
sagittal sinus during cerebral activity while the volume remains constant. This phenomenon
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ΔCHbO and ΔCHbR due to the sagittal sinus. This phenomenon is well-known and named the
washout effect of deoxyhemoglobin and could be studied in future works with biomechanical
modeling of the neurovascular coupling [19,52,53] by introducing a compartment representing
the sagittal sinus. In order to simulate the washout of [HbR] in the sinuses, blood volume
would remain constant while oxygen saturation would be free to experiment a variation in the
extra-cerebral compartment. In particular, a recent study [54] shown that a major component of
the low frequency oscillations detected by both DOI and fMRI arises from the propagation of
endogenous global blood ﬂow and oxygenation ﬂuctuations through the cerebral vasculature,
rather than from local variations in neuronal activation (i.e. not related to the task or resting state
connectivity) or localized cerebral blood ﬂow changes. The need of methods for quantifying the
signal contribution from extra-cerebral tissues is still justiﬁed [23,43].
5. Conclusion
In this study, we investigated the effect of the extra-cerebral vasculature on DOI measurements.
The results shown that the sagittal sinus inﬂuenced the recovery of changes in hemoglobin con-
centration. We tested several realistic optical conﬁgurations in which the effect of the sagittal
sinus was quantiﬁed. We demonstrated that modeling the extra-cerebral vasculature in the re-
covery procedure reduced the partial volume error by at least a factor of 1.4. The effect of the
extra-cerebral vasculature was also investigated in the context of a high-density diffuse optical
tomography. In this case, the effect of the vasculature was lower and the difference between
the two head models was less than 10% conﬁrming the ability of HD tomography procedure to
remove the signal contribution originated from superﬁcial tissues.
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